Measurement inconsistency across clinical trials is tackled by the development of a core outcome measurement set. Four core outcome domains were recommended for clinical trials in patients with non-specific LBP (nsLBP): physical functioning, pain intensity, health-related quality of life (HRQoL), and number of deaths. This study aimed to reach consensus on core instruments to measure the first three domains. The Steering Committee overseeing this project selected 17 potential core instruments for physical functioning, three for pain intensity, and five for HRQoL. Evidence on their measurement properties in nsLBP was synthesized in three systematic reviews using COSMIN methodology. Researchers, clinicians, and patients (n = 208) were invited in a Delphi survey to seek consensus on which instruments to endorse as core. Consensus was Background & purpose
Methods & Results
Metal-on-metal hip resurfacing is increasingly common. Patients suitable for hip resurfacing are often young, more active, may be in employment and may have bilateral disease. One-stage bilateral total hip replacement has been demonstrated to be as safe as a two-stage procedure and more cost effective. The aim of this study was to compare the in-patient events, outcome and survival in patients undergoing one-stage resurfacing with a two-stage procedure less than one-year apart.
No patients have undergone a revision procedure during the study period and no patient is awaiting revision surgery.
We wished to estimate the incidence of surgical-site infection (SSI) after total hip replacement (THR) and hemiarthroplasty and its strength of association with major risk factors. The SSI surveillance service prospectively gathered clinical, operative and infection data on inpatients from 102 hospitals in England during a four-year period. The overall incidence of SSI was 2.23% for 16 291 THRs, 4.97% for 5769 hemiarthroplasty procedures, 3.68% for 2550 revision THRs and 7.6% for 198 revision hemiarthroplasties.
There is an increasing interest amongst surgeons and demand from patients for hip resurfacing. One concern regarding resurfacing is the incidence of femoral neck fracture post operatively. McMinn and Treacy report an incidence of 0.4% in their series, our finding was of an incidence of over four times as high (1.9%). We looked at our database of hip resurfacings and tried to identify the risk factors for fracture. We identified 11 fractures and compared these with 22 controls selected by choosing the cases performed by the surgeon immediately before and after the fracture case. We analysed their medical notes and x-rays. Statistical analysis was performed using a package in ™Excel. The implants were either Birmingham Hip (Midland Medical Technologies) or Cormet (Corin) resurfacings. No statistically significant correlation was found for sex, age or body mass index. We found that fracture was twice as likely in the presence of possible or probable osteopenia. We did not find that fracture was more likely to occur in patients with a previous diagnosis of Perthes, DDH, SUFE and avascular necrosis (AVN). We found patients with a superior overhang of the femoral component on the neck did not risk fracture, however we could not demonstrate that notching in itself increased the risk of fracture. There was no correlation with neck-shaft and stem-shaft angle or neck lengthening and offset and subsequent neck fracture. In 13 bilateral cases there was fracture in 3 (incidence 23%). Apart from one fracture that occurred at 18 weeks post-operatively all the others occurred before eight weeks. Five fractures occurred in patients who subsequently on histological analysis were found to have avascular necrosis. We conclude that bilateral surgery is probably unwise. That a superior overhang seems to protect against fracture as long as this is not at the expense of creating an inferior notch. Finally, we find AVN in a number of retrieved heads, what is the true incidence of AVN and does the approach adopted cause the avascular process and if so why do we see so few fractures?
Data collected on total knee replacements (TKR) from 77 hospitals in England were analysed to identify risk factors for surgical site infection (SSI). Demographic, operative, and infection data were collected prospectively over a four-year period by the Nosocomial Infection National Surveillance Scheme. There were 213 (1.8%) infections reported in 11552 primary TKR of which 82% were superficial, 10% deep incisional, and 8% joint/bone infections. The incidence of SSI in 687 revision of TKRs was 4.1% (71% superficial incisional, 18% deep incisional and 11% joint/bone). In the single variable analysis of primary TKRs, significant risk factors were male sex (p<
0.01), age (p<
0.001), ASA score (p<
0.001), wound class (p<
0.001) and NNIS risk index (p<
0.001). In revision of TKRs, only age (p<
0.01) and pre-operative hospital stay of more than one day (p<
0.02) were found to be significant. Significant risk factors with multi-variable logistic regression were type of procedure (TKR or revision TKR), hospital where the procedure was performed, male sex, and age. The mean length of stay in primary TKRs was 10 days (19 days with SSI) and 12 days in revision TKR (22 days with SSI). The median time to diagnosis for superficial SSI was 7 days for superficial SSIs, 9 days for deep incisional SSIs and 7.5 days for joint/bone infections. Staphylococcus aureus accounted for 35% of the infections and nearly one third of these were methicillin resistant (MRSA). There is significant inter-hospital variation in the incidence of SSI following total knee replacement. Revision TKR procedures are associated with a significantly higher incidence of SSI than primary TKRs (p<
0.001). Male sex and age are also important risk factors. Patients with SSI had a length of post-operative stay approximately twice that of those without SSI.